68
Participants
Start Date
June 1, 2011
Primary Completion Date
April 16, 2012
Study Completion Date
April 16, 2012
EXC 001
Single-dose administered by injection four different times
EXC 001
Single reduced dose compared to Group 1 administered by injection at the same four time periods as Group 1
EXC 001
Single reduced dose compared to Groups 1 and 2 administered by injection at the same four time periods as Groups 1 and 2
EXC 001
Same sinlge dose as Group 1 administered by injection at the same four time periods as Groups 1, 2, and 3
Bayside Ambulatory Center, Miami
Aesthetic Plastic Surgery Miami, Miami
Altus Research, Lake Worth
Body Aesthetic Plastic Surgery, St Louis
Endeavor Clinical Trials,P.A., San Antonio
Bright Health Physicans Plastic Surgery and Aesthetic Medicine, Whittier
Skin Deep Laser Medical Spa, Pasadena
Connall Consmetic Surgery, Tualatin
Mark L. Jewell,MD Surgery Center, Eugene
BAXTER Plastic Surgery, Mountlake Terrace
New Jersey Plastic Surgery, Montclair
Texas Plastic Surgery, San Antonio
Lead Sponsor
Pfizer
INDUSTRY